Evidence-based multidisciplinary model of care for newborn screening in spinal muscular atrophy
Authors:
- Didu S. KariyawasamDKDidu S. Kariyawasam
- C. WedlakeCWC. Wedlake
Open Access
- 7 May 2026
- journal article
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (5) , 102560
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (2026317)
This publication has 18 references indexed in Scilit:
- Guidelines for reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophyPathology, 2025
- Spinal muscular atrophy in the UK: the human toll of slow decisionsThe Lancet, 2025
- Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort studyThe Lancet Child & Adolescent Health, 2023
- Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacyAnnals of Clinical and Translational Neurology, 2022
- Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to goNeuromuscular Disorders, 2021
- “We needed this”: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophyeClinicalMedicine, 2021
- Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE studyNeuromuscular Disorders, 2019
- The implementation of newborn screening for spinal muscular atrophy: the Australian experienceGenetics in Medicine, 2019
- Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethicsNeuromuscular Disorders, 2018
- Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional careNeuromuscular Disorders, 2018